Ontology highlight
ABSTRACT: Objective
To compare and contrast the efficacy and safety of patiromer and sodium zirconium cyclosilicate (ZS-9) in the treatment of hyperkalemia.Design
A systematic review and meta-analysis of phase II and III clinical trial data was completed.Patients or participants
Eight studies (two phase II and four phase III trials with two subgroup analyses) were included in the qualitative analysis, and six studies (two phase II and four phase III trials) were included in the meta-analysis.Measurements and results
Significant heterogeneity was found in the meta-analysis with an I2 value ranging from 80.6-99.6%. A random-effects meta-analysis was applied for all end points. Each clinical trial stratified results by hyperkalemia severity and dosing; therefo
SUBMITTER: Meaney CJ
PROVIDER: S-EPMC5388568 | biostudies-literature | 2017 Apr
REPOSITORIES: biostudies-literature